535 related articles for article (PubMed ID: 29323103)
21. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
22. Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells.
Jin S; Shen JN; Wang J; Huang G; Zhou JG
Cancer Biol Ther; 2007 Feb; 6(2):261-8. PubMed ID: 17218775
[TBL] [Abstract][Full Text] [Related]
23. Oridonin stabilizes retinoic acid receptor alpha through ROS-activated NF-κB signaling.
Cao Y; Wei W; Zhang N; Yu Q; Xu WB; Yu WJ; Chen GQ; Wu YL; Yan H
BMC Cancer; 2015 Apr; 15():248. PubMed ID: 25886043
[TBL] [Abstract][Full Text] [Related]
24. Hydroxyl radical (·OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells.
Yu Y; Fan SM; Song JK; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2012; 35(12):2148-59. PubMed ID: 23207767
[TBL] [Abstract][Full Text] [Related]
25. Proteomic and functional analyses demonstrate the involvement of oxidative stress in the anticancer activities of oridonin in HepG2 cells.
Wang H; Ye Y; Yu ZL
Oncol Rep; 2014 May; 31(5):2165-72. PubMed ID: 24627081
[TBL] [Abstract][Full Text] [Related]
26. Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways.
Michel HE; Menze ET
Eur J Pharmacol; 2019 Aug; 857():172422. PubMed ID: 31152701
[TBL] [Abstract][Full Text] [Related]
27. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
[TBL] [Abstract][Full Text] [Related]
28. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
[TBL] [Abstract][Full Text] [Related]
29. DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells.
Chen JT; Fong YC; Li TM; Liu JF; Hsu CW; Chang CS; Tang CH
Eur J Pharmacol; 2008 Nov; 597(1-3):19-26. PubMed ID: 18822283
[TBL] [Abstract][Full Text] [Related]
30. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
[TBL] [Abstract][Full Text] [Related]
31. Oridonin inhibits IL-1β-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-γ.
Jia T; Cai M; Ma X; Li M; Qiao J; Chen T
Int Immunopharmacol; 2019 Apr; 69():382-388. PubMed ID: 30776647
[TBL] [Abstract][Full Text] [Related]
32. Oridonin Inhibits Cell Proliferation and Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
Shang CH; Zhang QQ; Zhou JH
Inflammation; 2016 Apr; 39(2):873-80. PubMed ID: 26923246
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
34. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
[TBL] [Abstract][Full Text] [Related]
35. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
[TBL] [Abstract][Full Text] [Related]
36. Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells.
Pi J; Jin H; Jiang J; Yang F; Cai H; Yang P; Cai J; Chen ZW
Pharmacol Res; 2017 May; 119():479-489. PubMed ID: 28411855
[TBL] [Abstract][Full Text] [Related]
37. The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.
Zhang Z; Zheng Y; Zhu R; Zhu Y; Yao W; Liu W; Gao X
Cancer Lett; 2014 Oct; 352(2):203-13. PubMed ID: 25025927
[TBL] [Abstract][Full Text] [Related]
38. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
39. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma.
Wang Z; Yin F; Xu J; Zhang T; Wang G; Mao M; Wang Z; Sun W; Han J; Yang M; Jiang Y; Hua Y; Cai Z
J Exp Clin Cancer Res; 2019 Jan; 38(1):44. PubMed ID: 30704503
[TBL] [Abstract][Full Text] [Related]
40. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
